Detalhe da pesquisa
1.
Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry.
Rheumatology (Oxford);
2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38243722
2.
Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study.
Semin Arthritis Rheum;
64: 152240, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37500379
3.
Infection outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study.
Semin Arthritis Rheum;
64: 152313, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38044241
4.
Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis: a comprehensive evaluation of randomised controlled trials and observational studies.
Ann Rheum Dis;
83(2): 177-183, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37932010
5.
Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries.
Arthritis Res Ther;
25(1): 101, 2023 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37308978
6.
Abatacept: A Review of the Treatment of Polyarticular-Course Juvenile Idiopathic Arthritis.
Paediatr Drugs;
22(6): 653-672, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33029724
7.
Development of Resilience Among Rheumatoid Arthritis Patients: A Qualitative Study.
Arthritis Care Res (Hoboken);
72(9): 1257-1265, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31282121